A meta-analysis of epigenome-wide association studies in Alzheimer's disease highlights novel differentially methylated loci across cortex
Rebecca G. SmithiD, Ehsan PishvaiD, Gemma L. ShirebyiD, Adam R. SmithiD, Janou A. Y. RoubroeksiD, Eilis J. HannoniD, Greg WheildoniD, Diego MastroeniiD, Gilles GasparoniiD, Markus J. RiemenschneideriD, Armin GieseiD, Andrew J. SharpiD, Leonard C. SchalkwykiD, Vahram H. HaroutunianiD, Wolfgang ViechtbaueriD, Daniël van den HoveiD, Michael N. WeedoniD, Danielle L. Brokaw, Paul T. FrancisiD, Alan J. ThomasiD, Seth LoveiD, Kevin MorganiD, Jörn WalteriD, Paul D. ColemaniD, David Alan BennettiD, , Katie LunnoniD
Abstract
Epigenome-wide association studies of Alzheimers disease have highlighted neuropathology-associated DNA methylation differences, although existing studies have been limited in sample size and utilized different brain regions. Here, we combine data from six DNA methylomic studies of Alzheimers disease (N=1,453 unique individuals) to identify differential methylation associated with Braak stage in different brain regions and across cortex. We identify 236 CpGs in the prefrontal cortex, 95 CpGs in the temporal gyrus and ten CpGs in the entorhinal cortex at Bonferroni significance, with none in the cerebellum. Our cross-cortex meta-analysis (N=1,408 donors) identifies 220 CpGs associated with neuropathology, annotated to 121 genes, of which 84 genes have not been previously reported at this significance threshold. We have replicated our findings using two further DNA methylomic datasets consisting of a further > 600 unique donors. The meta-analysis summary statistics are available in our online data resource (www.epigenomicslab.com/ad-meta-analysis/).
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 169
- FWCI
- 2.88
- Field percentile
- top 6%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- DNA methylation signatures of Alzheimer's disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types
Gemma L. Shireby, Emma Louise Dempster, … Jonathan S. Mill·Nature CommunicationsPeer-reviewed·Sep 24, 2022
- Entorhinal cortex epigenome-wide association study highlights four novel loci showing differential methylation in Alzheimer's disease
Yasmine Sommerer, Valerija Dobričić, … Lars Bertram·Alzheimer s Research & TherapyPeer-reviewed·May 6, 2023
- Integrated DNA methylation and gene expression profiling across multiple brain regions implicate novel genes in Alzheimer’s disease
Stephen Andrew Semick, Rahul A. Bharadwaj, … Venkata Satyanand Mattay·Acta NeuropathologicaPeer-reviewed·Feb 2, 2019
- From aging to Alzheimer's disease: concordant brain DNA methylation changes in late life
David Lukacsovich, Juan I. Young, … Alzheimer’s Disease Neuroimaging Initiative·Genome MedicinePeer-reviewed·Jun 16, 2026
- A Cell-Type-Resolved Meta-Analysis Reveals Glial DNA Methylation Changes Associated with Aging and Alzheimer's Disease
Uchit Bhaskar, Mark Z. Kos, Melanie A. Carless·Alzheimer s & DementiaPeer-reviewed·Sep 1, 2026
- APOE Genotype-specific Methylation Patterns are Linked to Alzheimer Disease Pathology and Estrogen Response
Rebecca Panitch, Nathan J Sahelijo, … Gyungah Jun·medRxiv·Dec 20, 2022